{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:14:49Z","timestamp":1793016889180,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.canlet.2024.216802","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T04:38:28Z","timestamp":1710131908000},"page":"216802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma"],"prefix":"10.1016","volume":"588","author":[{"given":"Honghao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0982-6680","authenticated-orcid":false,"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.216802_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40364-023-00502-8","article-title":"Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications","volume":"11","author":"Chen","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2024.216802_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12915-020-00766-8","article-title":"Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1","volume":"18","author":"Gu","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.canlet.2024.216802_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2024.216802_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.molmed.2019.06.009","article-title":"The mitochondrion as an emerging therapeutic target in cancer","volume":"26","author":"Roth","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2024.216802_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41419-023-05775-3","article-title":"TIPE3 represses head and neck squamous cell carcinoma progression via triggering PGAM5 mediated mitochondria dysfunction","volume":"14","author":"Chen","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216802_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2019.07.015","article-title":"The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics","volume":"66","author":"Panigrahi","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2024.216802_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041112","article-title":"Autophagy\/mitophagy regulated by Ubiquitination: a promising pathway in cancer therapeutics","volume":"15","author":"Jee","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.216802_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121947","article-title":"Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics","volume":"293","author":"Ma","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2024.216802_bib9","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/ptr.7808","article-title":"Oxymatrine suppresses colorectal cancer progression by inhibiting NLRP3 inflammasome activation through mitophagy induction in vitro and in vivo","volume":"37","author":"Liang","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.canlet.2024.216802_bib10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12967-023-04067-w","article-title":"Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2\/PINK1","volume":"21","author":"Peng","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2024.216802_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41419-023-05711-5","article-title":"STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation","volume":"14","author":"Qin","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216802_bib12","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.7150\/thno.42478","article-title":"SR9009 induces a REV-ERB dependent anti-small-cell lung cancer effect through inhibition of autophagy","volume":"10","author":"Shen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2024.216802_bib13","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1007\/s00018-021-03774-1","article-title":"Mitophagy in tumorigenesis and metastasis","volume":"78","author":"Poole","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2024.216802_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2024.216802_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semcancer.2019.09.012","article-title":"Drug repurposing for breast cancer therapy: old weapon for new battle","volume":"68","author":"Aggarwal","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2024.216802_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044154","article-title":"Pharmacological Efficacy of repurposing drugs in the treatment of prostate cancer","volume":"24","author":"Louren\u00e7o","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.216802_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ph16030451","article-title":"Targeting Inflammation in non-small cell lung cancer through drug repurposing","volume":"16","author":"Rajasegaran","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.canlet.2024.216802_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12272-023-01445-2","article-title":"The function, mechanisms, and clinical applications of metformin: potential drug, unlimited potentials","volume":"46","author":"Liu","year":"2023","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.canlet.2024.216802_bib19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41419-023-06019-0","article-title":"Histone acetylation by HBO1 (KAT7) activates Wnt\/\u03b2-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216802_bib20","first-page":"1622","article-title":"EPS8-mediated regulation of multiple myeloma cell growth and survival","volume":"9","author":"Zhang","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2024.216802_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216802_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41419-022-04823-8","article-title":"Flubendazole induces mitochondrial dysfunction and DRP1-mediated mitophagy by targeting EVA1A in breast cancer","volume":"13","author":"Zhen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216802_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41586-021-03510-6","article-title":"Distinct fission signatures predict mitochondrial degradation or biogenesis","volume":"593","author":"Kleele","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216802_bib24","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1083\/jcb.201612106","article-title":"Mitochondrial fission facilitates the selective mitophagy of protein aggregates","volume":"216","author":"Burman","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2024.216802_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1254313","article-title":"Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations","volume":"11","author":"Pendleton","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2024.216802_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12091734","article-title":"Phlorotannins: novel Orally administrated bioactive compounds that induce mitochondrial dysfunction and oxidative stress in cancer","volume":"12","author":"Sim\u00f3n","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.canlet.2024.216802_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102892","article-title":"Differences in hepatocellular iron metabolism underlie sexual dimorphism in hepatocyte ferroptosis","volume":"67","author":"Tao","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2024.216802_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12967-023-04498-5","article-title":"Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer","volume":"21","author":"Rocca","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2024.216802_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2024.216802_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1236651","article-title":"Mitochondrial quality control in lung diseases: current research and future directions","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.canlet.2024.216802_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119841","article-title":"Aloe gel glucomannan induced colon cancer cell death via mitochondrial damage-driven PINK1\/Parkin mitophagy pathway","volume":"295","author":"Zhang","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.canlet.2024.216802_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2023.105669","article-title":"Curcumin induces mitophagy by promoting mitochondrial succinate dehydrogenase activity and sensitizes human papillary thyroid carcinoma BCPAP cells to radioiodine treatment","volume":"93","author":"Zhang","year":"2023","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.canlet.2024.216802_bib33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2018.09.022","article-title":"Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma","volume":"70","author":"Chen","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2024.216802_bib34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000445044","article-title":"Dihydroergotamine tartrate induces lung cancer cell death through apoptosis and mitophagy","volume":"61","author":"Chang","year":"2016","journal-title":"Chemotherapy"},{"key":"10.1016\/j.canlet.2024.216802_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fphar.2019.00172","article-title":"Research progress on PARP14 as a drug target","volume":"10","author":"Qin","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.canlet.2024.216802_bib36","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1038\/s41467-023-41737-1","article-title":"PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFN\u03b3-driven acquired resistance in preclinical cancer models","volume":"14","author":"Wong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216802_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109094","article-title":"PARP14 promotes the growth and glycolysis of acute myeloid leukemia cells by regulating HIF-1\u03b1 expression","volume":"242","author":"Zhu","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.canlet.2024.216802_bib38","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/s41375-022-01641-x","article-title":"PARP14 is a novel target in STAT6 mutant follicular lymphoma","volume":"36","author":"Mentz","year":"2022","journal-title":"Leukemia"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524001952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524001952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:43:44Z","timestamp":1760816624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524001952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":38,"alternative-id":["S0304383524001952"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216802","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216802"}}